Next steps for the sector as paper-based IFUs give way to digital alternatives.
Regulators in the life sciences industry are making clear moves to connect patients, physicians and other stakeholders across the healthcare system by implementing e-labelling initiatives.
The goal of these initiatives is to ensure a sustainable and consistently up-to-date information source for product and safety information that isn't dependent on paper.
This eBook assesses the latest regulatory expectations and timelines applicable to the medical device industry. It then sets out the practical next steps manufacturers and suppliers can take now – both to prepare for compliance and to maximise the opportunities operationally and for customers.
